346 related articles for article (PubMed ID: 35083817)
1. Roles of necroptosis in alcoholic liver disease and hepatic pathogenesis.
Zhou Y; Wu R; Wang X; Bao X; Lu C
Cell Prolif; 2022 Mar; 55(3):e13193. PubMed ID: 35083817
[TBL] [Abstract][Full Text] [Related]
2. Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis.
Afonso MB; Rodrigues PM; Carvalho T; Caridade M; Borralho P; Cortez-Pinto H; Castro RE; Rodrigues CM
Clin Sci (Lond); 2015 Oct; 129(8):721-39. PubMed ID: 26201023
[TBL] [Abstract][Full Text] [Related]
3. Nrf2 Knockdown Disrupts the Protective Effect of Curcumin on Alcohol-Induced Hepatocyte Necroptosis.
Lu C; Xu W; Zhang F; Shao J; Zheng S
Mol Pharm; 2016 Dec; 13(12):4043-4053. PubMed ID: 27764939
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of receptor-interacting protein kinase 1 improves experimental non-alcoholic fatty liver disease.
Majdi A; Aoudjehane L; Ratziu V; Islam T; Afonso MB; Conti F; Mestiri T; Lagouge M; Foufelle F; Ballenghien F; Ledent T; Moldes M; Cadoret A; Fouassier L; Delaunay JL; Aït-Slimane T; Courtois G; Fève B; Scatton O; Prip-Buus C; Rodrigues CMP; Housset C; Gautheron J
J Hepatol; 2020 Apr; 72(4):627-635. PubMed ID: 31760070
[TBL] [Abstract][Full Text] [Related]
5. Pterostilbene attenuates RIPK3-dependent hepatocyte necroptosis in alcoholic liver disease via SIRT2-mediated NFATc4 deacetylation.
Shao Y; Wang X; Zhou Y; Jiang Y; Wu R; Lu C
Toxicology; 2021 Sep; 461():152923. PubMed ID: 34474091
[TBL] [Abstract][Full Text] [Related]
6. Emerging roles of Sirtuins in alleviating alcoholic liver Disease: A comprehensive review.
Zhao X; Xue X; Wang C; Wang J; Peng C; Li Y
Int Immunopharmacol; 2022 Jul; 108():108712. PubMed ID: 35397391
[TBL] [Abstract][Full Text] [Related]
7. Hepatic non-parenchymal cells: Master regulators of alcoholic liver disease?
Seo W; Jeong WI
World J Gastroenterol; 2016 Jan; 22(4):1348-56. PubMed ID: 26819504
[TBL] [Abstract][Full Text] [Related]
8. The epigenetic regulator SIRT6 protects the liver from alcohol-induced tissue injury by reducing oxidative stress in mice.
Kim HG; Huang M; Xin Y; Zhang Y; Zhang X; Wang G; Liu S; Wan J; Ahmadi AR; Sun Z; Liangpunsakul S; Xiong X; Dong XC
J Hepatol; 2019 Nov; 71(5):960-969. PubMed ID: 31295533
[TBL] [Abstract][Full Text] [Related]
9. SNX10 mediates alcohol-induced liver injury and steatosis by regulating the activation of chaperone-mediated autophagy.
You Y; Li WZ; Zhang S; Hu B; Li YX; Li HD; Tang HH; Li QW; Guan YY; Liu LX; Bao WL; Shen X
J Hepatol; 2018 Jul; 69(1):129-141. PubMed ID: 29452206
[TBL] [Abstract][Full Text] [Related]
10. The Receptor Interacting Protein Kinases in the Liver.
Dara L
Semin Liver Dis; 2018 Feb; 38(1):73-86. PubMed ID: 29471568
[TBL] [Abstract][Full Text] [Related]
11. NIK links inflammation to hepatic steatosis by suppressing PPARα in alcoholic liver disease.
Li Y; Chen M; Zhou Y; Tang C; Zhang W; Zhong Y; Chen Y; Zhou H; Sheng L
Theranostics; 2020; 10(8):3579-3593. PubMed ID: 32206109
[No Abstract] [Full Text] [Related]
12. Programmed cell death in alcohol-associated liver disease.
Miyata T; Nagy LE
Clin Mol Hepatol; 2020 Oct; 26(4):618-625. PubMed ID: 32951412
[TBL] [Abstract][Full Text] [Related]
13. Recent Advances in Understanding of Pathogenesis of Alcohol-Associated Liver Disease.
Wu X; Fan X; Miyata T; Kim A; Cajigas-Du Ross CK; Ray S; Huang E; Taiwo M; Arya R; Wu J; Nagy LE
Annu Rev Pathol; 2023 Jan; 18():411-438. PubMed ID: 36270295
[TBL] [Abstract][Full Text] [Related]
14. Molecular Insights into the Mechanism of Necroptosis: The Necrosome As a Potential Therapeutic Target.
Chen J; Kos R; Garssen J; Redegeld F
Cells; 2019 Nov; 8(12):. PubMed ID: 31766571
[TBL] [Abstract][Full Text] [Related]
15. A Mechanistic Review of Cell Death in Alcohol-Induced Liver Injury.
Wang S; Pacher P; De Lisle RC; Huang H; Ding WX
Alcohol Clin Exp Res; 2016 Jun; 40(6):1215-23. PubMed ID: 27130888
[TBL] [Abstract][Full Text] [Related]
16. Intermittent hypoxia aggravates non-alcoholic fatty liver disease via RIPK3-dependent necroptosis-modulated Nrf2/NFκB signaling pathway.
Zhang H; Zhou L; Zhou Y; Wang L; Jiang W; Liu L; Yue S; Zheng P; Liu H
Life Sci; 2021 Nov; 285():119963. PubMed ID: 34536498
[TBL] [Abstract][Full Text] [Related]
17. Nuclear factor (erythroid-derived 2)-like 2 activation-induced hepatic very-low-density lipoprotein receptor overexpression in response to oxidative stress contributes to alcoholic liver disease in mice.
Wang Z; Dou X; Li S; Zhang X; Sun X; Zhou Z; Song Z
Hepatology; 2014 Apr; 59(4):1381-92. PubMed ID: 24170703
[TBL] [Abstract][Full Text] [Related]
18. Oxidative mechanisms in the pathogenesis of alcoholic liver disease.
Albano E
Mol Aspects Med; 2008; 29(1-2):9-16. PubMed ID: 18045675
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of apoptosis protects mice from ethanol-mediated acceleration of early markers of CCl4 -induced fibrosis but not steatosis or inflammation.
Roychowdhury S; Chiang DJ; Mandal P; McMullen MR; Liu X; Cohen JI; Pollard J; Feldstein AE; Nagy LE
Alcohol Clin Exp Res; 2012 Jul; 36(7):1139-47. PubMed ID: 22273278
[TBL] [Abstract][Full Text] [Related]
20. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
Wang M; Ma LJ; Yang Y; Xiao Z; Wan JB
Crit Rev Food Sci Nutr; 2019; 59(sup1):S116-S129. PubMed ID: 30580553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
